Tonix Pharmaceuticals Holding (TNXP) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 0.92.
- Tonix Pharmaceuticals Holding's Equity Ratio rose 1720.0% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year increase of 1720.0%. This contributed to the annual value of 0.86 for FY2024, which is 2540.43% up from last year.
- Tonix Pharmaceuticals Holding's Equity Ratio amounted to 0.92 in Q3 2025, which was up 1720.0% from 0.9 recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Equity Ratio ranged from a high of 0.94 in Q1 2025 and a low of 0.6 during Q2 2024
- Moreover, its 3-year median value for Equity Ratio was 0.87 (2023), whereas its average is 0.83.
- In the last 5 years, Tonix Pharmaceuticals Holding's Equity Ratio tumbled by 3189.87% in 2024 and then skyrocketed by 4973.48% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Equity Ratio (Quarter) stood at 0.68 in 2023, then increased by 25.4% to 0.86 in 2024, then rose by 6.87% to 0.92 in 2025.
- Its Equity Ratio was 0.92 in Q3 2025, compared to 0.9 in Q2 2025 and 0.94 in Q1 2025.